Webinar #NotJustLyme 7 November 2018
ABOUT THE WEBINAR #NOTJUSTLYME
Clinical diagnosis of tick-borne diseases such as Lyme disease has become a grave socio-economic concern in more than 80 countries all over the globe. However, research in the field of tick-borne diseases have mainly examined diagnosis, treatment, and persistence of Lyme disease, reporting of co-infections or emerging infections, cellular immune responses to tick-borne infections, and the distribution of ticks globally or locally. Although several research articles indicate various microbes that ticks can carry, only a handful human case studies elucidate the involvement of certain co-infections in patients who have the Lyme disease, and there are no comments on the opportunistic infections that tick-borne disease patients may experience. This webinar is all about the prevalence and relevance of multiple microbial infections in tick-borne disease patients. The impact of Dr. Leona Gilbert’s work is highly relevant as it establishes the need to reform clinical practice and health care policies for diagnosing tick-borne diseases. Screening for various microbes would decrease the rate of misdiagnosis or undiagnosed cases, increase the health-related quality of life for the patients, and may ultimately drive clinical research to discover a treatment for tick-borne diseases and not just Lyme disease.
BIOGRAPHY DR. LEONA GILBERT
Dr. Leona Gilbert is an Docent of Cell and Molecular Biology at the University of Jyväskylä, Finland and she is the CEO of Te?ted Oy, a university spinoff company that has a goal tog et the patient tested so they can be treated. She has a PhD in Biotechnology and a very long experience in bioinnovation and biobusiness. She supervises various PhD, MSc and BSc students and is extremely active in lecturing undergraduate and graduate courses at the University of Jyväskylä. Her numerous peer reviewed articles span turning research results into translational value with developing novel delivery vectors that can be used for imaging and biotechnological tools as well as to developing diagnostic lab-on-chip platforms. In addition Dr. Gilbert’s publications also demonstrate the thorough investigation of how a common virus or bacterium can contribute to autoimmune diseases. Another highlight in these publications is the demonstration of a multi-disciplinary background and collaborative effort between microbiologists, diagnostic developers, nano-scientists, physicists and engineers. Leona knows how to build effective and loyal teams. Concurrent research in Borrellia and Human parvovirus lead to her initiation and involvement in national, EU and international projects to develop a highly sensitive and specific vector-borne disease diagnostic tests. Dr. Gilbert’s research initiatives into complete diagnostic platforms and clinical profiling of patients for tick-borne diseases will allow a better understanding of how chronic conditions could be established with tick-borne pathogen infections. Because of the breakthroughs in her research group, Dr. Gilbert has established Te?ted Oy in Oct 2016 with the goal to improve diagnostic for tick-borne diseases.